Full text is available at the source.
Electrochemical Biosensor Based on a Tetrahedral DNA Nanostructure and an “AND” Logic Gate-Regulated Cascade Amplification System for Parallel Detection of Dual Disease Biomarkers
Electrochemical sensor using DNA structures and logic-controlled signal boosts to detect two disease markers at once
AI simplified
Abstract
Detection limits for AFP and miRNA-122 are as low as 4.05 fg/mL and 34.84 aM respectively.
- An electrochemical biosensor was developed to detect AFP and miRNA-122 simultaneously.
- The sensor utilizes a tetrahedral DNA nanostructure and an 'AND' logic gate mechanism for signal amplification.
- The detection relies on parallel amplification processes triggered by specific biomarkers.
- Significant signal changes occur only when both AFP and miRNA-122 are present, enhancing specificity.
- The biosensor successfully differentiated between healthy individuals and HCC patients in real serum samples.
AI simplified